David Matthew T 4
4 · CorMedix Inc. · Filed Jan 18, 2023
Insider Transaction Report
Form 4
CorMedix Inc.CRMD
David Matthew T
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy Common Stock)
2023-01-14+125,000→ 125,000 totalExercise: $4.43Exp: 2033-01-14→ Common Stock (125,000 underlying)
Holdings
- 3,150
Common Stock
Footnotes (1)
- [F1]These options were granted on 1/14/2023. These options vest 1/4 on the date of grant, and, subject to continued employment, 1/4 on the first anniversary of the date of grant, 1/4 on the second anniversary of the date of grant and 1/4 on the third anniversary of the date of grant.